Discovery and Potential Use for Alzheimer's with TAT-cn peptide against Tau Protein
Discovery and Potential Use for Alzheimer's with TAT-cn peptide against Tau Protein Researchers at the University of Texas Southwestern Medical Center, led by Dr. Marc Diamond, discovered a synthetic peptide called TAT-Cn that targets the tau protein, which is implicated in Alzheimer's disease. This peptide can be administered intranasally, allowing it to cross the blood-brain barrier and reach the brain efficiently. TAT-Cn works by inhibiting the interaction between tau and the enzyme dynamin, thus preventing tau's harmful effects on synaptic function. This approach has shown promise in reversing Alzheimer's symptoms in mouse models, suggesting potential for human therapeutic use in the future ( UTSW Med Center ) ( SciTechDaily ) . Detection of Tau Protein Detection of tau protein levels can be achieved through analysis of cerebrospinal fluid (CSF) and blood samples. These tests are designed to measure the concentration of tau and its phosphorylated forms, which...